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Introduction
Despite common dose–response curves, a compound may have
the opposite effect in small doses as in large doses. This phe-
nomenon is named hormesis. Calabrese et al have reported that
many toxic substances, environmental hormones, inorganic
compounds, and even irradiation induce hormesis. They mod-
ulate the growth of cultured cells in a biphasic fashion, either
stimulating or inhibiting the growth of cultured cells at low and
high concentrations, respectively.1,2
There are 2 hormetic models: overcompensation stimulation
and direct stimulation. Overcompensation stimulation is based
on observations that the hormetic stimulatory response in the
low-dose zone (ie, below the traditional toxic threshold) can
result from an overcompensation following an initial disruption
in homeostasis.3 With respect to the time component of this
model, the dose response is a series of time-based snapshots.3
Contrary to overcompensation stimulation, direct stimula-
tion model employs multiple doses with only 1 time point. It
can happen by 2 mechanisms: receptor-mediated or cell-
signaling-mediated. In several studies, researchers identified
an essential cell-signaling pathway as well as the receptor.4
Umbelliprenin (umb) is a naturally sesquiterpene coumarin,
which is synthesized by ferula species. Apoptosis induction is
one of the umb effects. Ziai et al investigated the properties of
this effect.5-7 Based on our previous findings,7 part of our
previous data will be reanalyzed with respect to hormetic
dose–response relationship.
Materials and Methods
In our previous study,7 we incubated Jurkat T-CLL cells with
different concentrations (10, 25, 50, and 100 mM) for different
times (16, 20, 24, and 48 hours). The cytotoxicity and apoptosis
induction (total apoptosis, total necrosis, early apoptosis, and
late apoptosis) were measured by annexin V-FITC/PI double
staining flow cytometry. Part of the study was published7; here,
part of the previous data is presented by Microsoft Excel 2010
and interpreted based on hormesis phenomenon.
Results
Based on our previous findings,7 we found the hormetic phe-
nomenon for some of the times of incubation (but not for all of
them). The best hormetic effect is found for total and late
apoptosis after 48 hours of incubation (Figure 1).
Discussion
The hormetic dose–response relationship has become the
object of considerable investigation across the broad range
of biological/biomedical disciplines concerned with dose/
concentration–response relationships over the past 2 decades.4
Hormetic models are overcompensation stimulation and direct
stimulation. While overcompensation is tested based on multi-
ple doses with multiple time points, direct stimulation employs
multiple doses with only 1 time point.
Because of umb-induced/inhibited apoptosis in multiple
doses with only 1 time point, we can conclude that total and late
apoptosis induction by different concentrations of umb followed
direct stimulation hormetic model (Figure 1).
In our previous findings, we showed that umb activates
intrinsic and extrinsic pathways of apoptosis by the activation
of caspase-8 and -9, respectively.5,6 The extrinsic pathway of
apoptosis is mediated by tumor necrosis factor receptor. There-
fore, based on professor Calabrese’s findings, umb has a hor-
metic mechanism for both receptor and signaling pathway.4
Szabaldi documented numerous examples of biphasic dose
responses in the pharmacological literature. He showed that it
was mediated by a single agonist acting upon 2 receptor sub-
types, one affecting a stimulatory pathway and the other an
inhibitory pathway. Although the subtype affecting the
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stimulatory pathway had far fewer receptors with considerably
greater affinity for the agonist, the subtype affecting inhibition
typically had far less affinity for the agonist but much greater
capacity (ie, more receptors).8 We can conclude that umb med-
iates its hormetic effect by 2 subtype receptors. This hypothesis
requires further analysis in the future.
In conclusion, hormetic phenomenon was observed in the
apoptosis induction/inhibition by umb at different times of
incubation. However, the present data may not suffice for the
complete interpretation of its hormetic effect and requires fur-
ther elucidation.
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Figure 1. Total (A) and late (B) apoptosis induction by umbelliprenin after 48 hours incubation in Jurkat cells. Umbelliprenin induces and inhibits
apoptosis by hormetic effect. In low doses, umbelliprenin increases the percentage of apoptosis, and in high doses, it decreases the percentage of
apoptosis. Data are shown as mean + standard deviation. Error bars represent 95% confidence interval.
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